The landscape of dementia diagnosis has progressed radically with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that will detect Alzheimer's pathology many years before indications arise. Even though these technological developments represent remarkable development in knowing neurodegenerative illnesses, they may have not https://mildcognitiveimpairmentte88776.activosblog.com/36801090/the-enduring-price-of-cognitive-assessment-for-older-older-people